Enavogliflozin is a highly selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor that exhibits potent antidiabetic activity. By inhibiting SGLT-2, Enavogliflozin reduces glucose reabsorption in the kidneys, promoting increased glucose excretion in urine and thereby lowering blood glucose levels. This compound is primarily employed in research applications focused on diabetes management and cardiovascular health.
Enavogliflozin is a highly selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor that exhibits potent antidiabetic activity. By inhibiting SGLT-2, Enavogliflozin reduces glucose reabsorption in the kidneys, promoting increased glucose excretion in urine and thereby lowering blood glucose levels. This compound is primarily employed in research applications focused on diabetes management and cardiovascular health.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
